CN113402563A - Iridium complex, preparation method thereof, organic electroluminescent device and display device - Google Patents

Iridium complex, preparation method thereof, organic electroluminescent device and display device Download PDF

Info

Publication number
CN113402563A
CN113402563A CN202110664383.2A CN202110664383A CN113402563A CN 113402563 A CN113402563 A CN 113402563A CN 202110664383 A CN202110664383 A CN 202110664383A CN 113402563 A CN113402563 A CN 113402563A
Authority
CN
China
Prior art keywords
iridium complex
equal
formula
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110664383.2A
Other languages
Chinese (zh)
Other versions
CN113402563B (en
Inventor
王辉
李小龙
卢振阳
段伟伟
刘志远
李猛
马晓宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Optical and Electronic Materials Co Ltd
Original Assignee
Jilin Optical and Electronic Materials Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Optical and Electronic Materials Co Ltd filed Critical Jilin Optical and Electronic Materials Co Ltd
Priority to CN202110664383.2A priority Critical patent/CN113402563B/en
Publication of CN113402563A publication Critical patent/CN113402563A/en
Application granted granted Critical
Publication of CN113402563B publication Critical patent/CN113402563B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention discloses an iridium complex, a preparation method thereof, an organic electroluminescent device and a display device, belonging to the field of organic photoelectric materials, wherein the iridium complex has a structural general formula as follows:

Description

Iridium complex, preparation method thereof, organic electroluminescent device and display device
Technical Field
The invention relates to the field of organic photoelectric materials, in particular to an iridium complex, a preparation method thereof, an organic electroluminescent device and a display device.
Background
With the development of multimedia information technology, users have higher and higher requirements for the performance of display devices such as flat panels, notebooks, and the like. Compared with liquid crystal display devices, organic electroluminescent devices (OLEDs) do not need a backlight source, and have the advantages of wider viewing angle, low power consumption, high response speed and the like, so the OLEDs have wider application prospects.
Among them, the luminescent materials of OLEDs are mainly phosphorescent luminescent materials, and the metal iridium complex is a phosphorescent luminescent material which is widely studied at present. However, the conventional OLEDs using the iridium complex as a light emitting material still have the problems of high driving voltage, low light emitting efficiency, short service life, and the like.
Disclosure of Invention
An object of the embodiments of the present invention is to provide an iridium complex to solve the problems in the background art.
In order to achieve the above purpose, the embodiments of the present invention provide the following technical solutions:
an iridium complex has a general structural formula of formula I:
Figure BDA0003116705420000011
wherein m is a positive integer of not more than 3, and when m is 3, an a ring is absent; when m is 1 or 2, the ring A is a cyclic structure;
a. b and c are integers, a is more than or equal to 0 and less than or equal to 4, b is more than or equal to 0 and less than or equal to 2, and c is more than or equal to 1 and less than or equal to 4;
x is O or S, Y is N or P;
R1、R2and R3Is at any position of the ring and is independently selected from at least one of hydrogen, deuterium, amino, hydroxyl, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C1-C30 alkoxy, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted 4-30-membered aromatic heterocyclic group, substituted or unsubstituted C10-C30 condensed ring group, substituted or unsubstituted C5-C30 spiro ring; and at least one R3Is fluorine.
Wherein two or more substituents R in the same molecule1、R2And R3May have different meanings. R1,R2,R3Or can form an aromatic ring or an aromatic heterocyclic ring or a ring system with the ring on which the compound is arranged.
Specifically, the a ring may be one of a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, or an eight-membered ring. Preferably, R1,R2,R3At least one group of which forms a ring with the ring structure in which it is located.
Preferably, the structural general formula of the iridium complex is any one of formula 01 to formula 04:
Figure BDA0003116705420000021
in the formula, R4、R5、R6、R7And R8Each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted 4-to 30-membered aromatic heterocyclic group, substituted or unsubstituted C10-C30 condensed ring group; r7And R8At any position of the ring; r7,R8Or can form an aromatic ring or an aromatic heterocyclic ring or a ring system with the ring; d. e, f, g and h are integers, d is more than or equal to 0 and less than or equal to 1, e is more than or equal to 0 and less than or equal to 2, f is more than or equal to 0 and less than or equal to 2, g is more than or equal to 0 and less than or equal to 4, and h is more than or equal to 0 and less than or equal to 4. Preferably, R7And/or R8Form a ring knot with the ring on which it is arrangedAnd (5) forming. Preferably, the iridium complex has a chemical structural formula of any one of the following formulas:
Figure BDA0003116705420000022
Figure BDA0003116705420000031
Figure BDA0003116705420000041
Figure BDA0003116705420000051
Figure BDA0003116705420000061
Figure BDA0003116705420000071
Figure BDA0003116705420000081
Figure BDA0003116705420000091
Figure BDA0003116705420000101
Figure BDA0003116705420000111
Figure BDA0003116705420000121
some specific structural forms are listed above, but the series of compounds are not limited to the above molecular structures, and other specific molecular structures can be obtained through simple transformation of some simple groups, substituted groups and substituted positions thereof, and are not described in detail herein.
Another object of the embodiments of the present invention is to provide a preparation method of the iridium complex, which includes the following steps:
reacting the raw material A with iridium trichloride to obtain an intermediate B;
reacting the intermediate B with the raw material C to obtain the iridium complex; or reacting the intermediate B with silver trifluoromethanesulfonate to obtain an intermediate C, and then reacting the intermediate C with the raw material D to obtain the iridium complex;
wherein the structural formulas of the raw material A and the raw material D are respectively and independently formula A-01 or formula A-02:
Figure BDA0003116705420000131
the structural formula of the raw material C is represented by formula C-01:
Figure BDA0003116705420000132
specifically, the synthetic route of formula 01 is as follows:
Figure BDA0003116705420000133
the synthetic route for formula 02 is as follows:
Figure BDA0003116705420000141
the synthetic route for formula 03 is as follows:
Figure BDA0003116705420000151
the synthetic route for formula 04 is as follows:
Figure BDA0003116705420000152
another object of the embodiments of the present invention is to provide an application of the iridium complex in preparation of organic electroluminescent devices.
It is another object of an embodiment of the present invention to provide an organic electroluminescent device, including a first electrode, a second electrode, and at least one organic layer disposed between the first electrode and the second electrode, where the organic layer includes the iridium complex described above.
Preferably, the organic layer includes a light emitting layer; the light-emitting layer comprises a host material and a doping material; the doping material partially or entirely comprises the iridium complex. Specifically, the iridium complex is in a single form or is mixed with other substances and exists in the organic layer. Preferably, the organic layer includes at least one or more of a hole injection layer, a hole transport layer, a layer having both hole injection and hole transport technologies, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer, and a layer having both electron transport and electron injection technologies. Preferably, the mixing ratio of the main material to the doping material is 90: 10-99.5: 0.5. Preferably, the organic electroluminescent device may be used for an organic light emitting device, an organic solar cell, electronic paper, an organic photoreceptor, or an organic thin film transistor.
Another object of an embodiment of the present invention is to provide a display apparatus, including a functional module and a display module, where the display module includes the above organic electroluminescent device.
Compared with the prior art, the embodiment of the invention has the beneficial effects that: according to the iridium complex provided by the embodiment of the invention, the specific heterocyclic ligand is selected to be coordinated and combined with iridium, so that the wavelength of the iridium complex can be adjusted, and after the iridium complex is used for an organic electroluminescent device, the luminous efficiency of the organic electroluminescent device can be obviously improved, the service life of the organic electroluminescent device can be prolonged, and the driving voltage of the organic electroluminescent device can be reduced. In addition, the preparation method of the iridium complex provided by the embodiment of the invention has the advantages of simple process and high purity of the prepared product.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. The iridium complexes described below are used as examples in the examples of the present invention, and the preparation methods of the other iridium complexes are similar and will not be further illustrated herein.
Example 1
This example provides an iridium complex of formula i-2, which is prepared by the following reaction scheme:
Figure BDA0003116705420000161
the specific preparation method comprises the following steps:
ligand A-2(14.57g,50mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.76g,22mmo1) is put into a reaction system, a mixed solution of 300m1 ethylene glycol ethyl ether and 100m1 pure water is added, the mixture is refluxed for 25 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The mass of the bridged ligand B-2 obtained was 9.42g in the form of a dark red powder, with a yield of 53%.
Then weighing the bridging ligand B-2(8.90g,5.5mmol), adding anhydrous potassium carbonate (7.59g,55mmol), adding 170ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-2(2.20g,22mmol) under nitrogen, refluxing for 24 hours under nitrogen protection, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, and concentrating the filtrate to precipitate solid, thereby finally obtaining the iridium complex shown in the formula I-2, wherein the mass of the iridium complex is 3.64 g. The yield was 38% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 871.96; the test value was 871.43.
The calculated value of the elemental analysis (%) is 59.23; h is 3.81; f is 4.36; 22.04 parts of Ir; n is 3.21; o is 7.34, and the test value C is 59.25; h is 3.82; f is 4.38; 22.02 parts of Ir; n is 3.20; o is 7.32.
Example 2
This example provides an iridium complex of formula I-11, which is prepared by the following reaction scheme:
Figure BDA0003116705420000171
the specific preparation method comprises the following steps:
ligand A-11(21.07g,50mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.76g,22mmo1) is put into a reaction system, mixed solution of 420m1 ethylene glycol ethyl ether and 140m1 pure water is added, the mixture is refluxed for 25 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The mass of the bridged ligand B-11 obtained was 11.99g in the form of a dark red powder, in 51% yield.
Then weighing the bridging ligand B-11(11.75g,5.5mmol), adding anhydrous potassium carbonate (7.59g,55mmol), adding 230ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-11(3.27g,16.5mmol) under nitrogen, refluxing for 24 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the iridium complex shown in the formula I-11, wherein the mass of the iridium complex is 4.33 g. The yield was 32% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 1230.39 test 1230.16.
The calculated value of the elemental analysis (%) is 66.38; h is 4.34; f is 6.18; 15.62 parts of Ir; 2.28 of N; o is 5.20, and the test value is 66.35; h is 4.32; f is 6.17; 15.65 parts of Ir; 2.28 of N; o is 5.23.
Example 3
This example provides an iridium complex of formula I-44, which is prepared by the following reaction scheme:
Figure BDA0003116705420000181
the specific preparation method comprises the following steps:
ligand A-44(25.28g,60mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, a mixed solution of 500m1 ethylene glycol ethyl ether and 167m1 purified water is added, the mixture is refluxed for 24 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The mass of the bridged ligand B-44 was 12.61g, a dark red powder was obtained in 59% yield.
Then weighing the bridging ligand B-44(10.68g,5mmol), adding anhydrous potassium carbonate (6.9g,50mmol), adding 210ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-44(3.18g,15mmol) under nitrogen, refluxing for 20 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as solvent, using neutral alumina column chromatography, concentrating the filtrate, and precipitating solid to obtain iridium complex shown in formula I-44 with mass of 4.23 g. The yield was 34% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 1244.32; the test value was 1244.19.
The calculated value of the elemental analysis (%) is C: 60.81; h is 4.13; f is 12.21; 15.45 parts of Ir; 2.25 of N; o is 5.14, and the test value is C is 60.80; h is 4.10; f is 12.22; 15.43 parts of Ir; 2.28 of N; o is 5.16.
Example 4
This example provides an iridium complex of formula I-62, which is prepared by the following reaction scheme:
Figure BDA0003116705420000191
the specific preparation method comprises the following steps:
ligand A-62(14.79g,44mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, a mixed solution of 300m1 ethylene glycol ethyl ether and 100m1 pure water is added, reflux is carried out for 28 hours under the protection of nitrogen, then cooling is carried out to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The mass of the bridged ligand B-62 was 11.68g, which was obtained as a dark red powder in 65% yield.
Then weighing the bridging ligand B-62(10.78g,6mmol), adding anhydrous potassium carbonate (8.28g,60mmol), adding 210ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-62(7.21g,30mmol) under nitrogen, refluxing for 20 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, and concentrating the filtrate to precipitate solid, thereby finally obtaining the iridium complex shown in the formula I-62 with the mass of 5.55 g. The yield was 42% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 1102.06; the test value was 1102.40.
Elemental analysis (%): calculated value is C: 53.40; h is 3.57; f, 17.24; 17.44 parts of Ir; n is 2.54; o is 5.81, and the test value is 53.41; h is 3.59; f, 17.25; 17.44 parts of Ir; n is 2.51; o is 5.80.
Example 5
This example provides an iridium complex of formula I-83, which is prepared by the following reaction scheme:
Figure BDA0003116705420000201
the specific preparation method comprises the following steps:
weighing the formula A-83(20.06g,54mmol), IrC1 under nitrogen protection3·3H2O (7.05g,20mmo1) was put into the reaction system, a mixed solution of 410m1 ethylene glycol ethyl ether and 140m1 purified water was added thereto, and the mixture was refluxed for 28 hours under nitrogen protection, and then heatedCooling to room temperature, precipitating, filtering, washing with water, anhydrous alcohol, and petroleum ether, and oven drying. The mass of the bridged ligand B-83 obtained was 11.23g in the form of a dark red powder, in 58% yield.
Then weighing the bridging ligand B-83(9.68g,5mmol), adding anhydrous potassium carbonate (6.9g,50mmol), adding 200ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-83(4.61g,20mmol) under nitrogen, refluxing for 20 hours under nitrogen protection, cooling, filtering, washing with alcohol, and drying. Dichloromethane is used as a solvent, neutral alumina column chromatography is carried out, filtrate is concentrated, solid is precipitated, and finally the iridium complex shown in the formula I-83 is obtained, wherein the mass of the iridium complex is 3.37 g. The yield was 29% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 1162.29; the test value was 1162.53.
Elemental analysis (%): calculated value is C: 63.04; h is 4.34; f is 8.17; 16.54 parts of Ir; 2.41 of N; o is 5.51, and the test value is C is 63.06; h is 4.35; f is 8.18; 16.52 parts of Ir; 2.40 of N; o is 5.50.
Example 6
This example provides an iridium complex of formula i-96, which is prepared by the following reaction scheme:
Figure BDA0003116705420000211
the specific preparation method comprises the following steps:
weighing the formula A-96(21.26g,50mmol), IrC1 under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, mixed solution of 420m1 ethylene glycol ethyl ether and 140m1 purified water is added, reflux is carried out for 28 hours under the protection of nitrogen, then cooling is carried out to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The mass of the bridged ligand B-96 was 10.98g, which was obtained in the form of a dark red powder, in 51% yield.
Then weighing the bridging ligand B-96(10.76g,5mmol), adding anhydrous potassium carbonate (6.9g,50mmol), adding 210ml of ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula C-96(7.05g,25mmol) under nitrogen, refluxing for 20 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, and concentrating the filtrate to separate out solid, thereby finally obtaining the iridium complex shown in the formula I-96 with the mass of 3.17 g. The yield was 24% and the HPLC purity was greater than 99.5%.
Mass spectrum calculated 1321.72; the test value was 1321.41.
Elemental analysis (%): calculated value is C: 39.08; h is 0.61; f, 38.81; 14.54 parts of Ir; 2.12 of N; o:4.84, test value C: 39.09; h is 0.63; 38.84 is used as a reference material; 14.52 parts of Ir; 2.11 of N; o is 4.81.
Example 7
This example provides an iridium complex of formula i-100, which is prepared by the following reaction scheme:
Figure BDA0003116705420000221
the specific preparation method comprises the following steps:
weighing formula A-100(9.31g,60mmol), IrC1 under nitrogen protection3·3H2O (20mmo1,7.05g) is put into a reaction system, a mixed solution of 180m1 ethylene glycol ethyl ether and 60m1 pure water is added, the mixture is refluxed for 24 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The bridged ligand B-100 was obtained as a yellow powder (4.61g, 43% yield).
Weighing the intermediate B-100(4.29g and 4mmol), adding silver trifluoromethanesulfonate (2.26g and 8.8mmol), adding 90ml of dichloromethane into the system, adding 30ml of methanol, refluxing for 24 hours under the protection of nitrogen, cooling to room temperature, and concentrating the filtrate of column chromatography (short column) until solid is separated out. The iridium complex intermediate of formula C-100 was obtained as a yellow powder (5.52g, 97% yield).
Weighing the intermediate C-100(4.98g,7mmol), adding the ligand D-100(6.43g,17.5mmol), adding 100ml of absolute ethanol into the system, refluxing for 24 hours under the protection of nitrogen, filtering, washing with alcohol, and drying. The filtrate was concentrated by column chromatography on silica gel using methylene chloride as solvent to give the final yellow compound of formula I-100 (1.27g, 21% yield) with an HPLC purity of greater than 99%.
Mass spectrum calculated 867.02 test 867.30.
Elemental analysis (%). calcd for C: 65.11; h is 3.84; f is 2.19; 22.17 parts of Ir; n is 4.85; o is 1.85, and the test value is 65.12; h is 3.86; f is 2.19; 22.15 parts of Ir; n is 4.85; o is 1.86.
Example 8
This example provides an iridium complex of formula I-114, which is prepared by the following reaction scheme:
Figure BDA0003116705420000231
the specific preparation method comprises the following steps:
formula A-114(14.57g,50mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, mixed solution of 290m1 ethylene glycol ethyl ether and 97m1 pure water is added, reflux is carried out for 28 hours under the protection of nitrogen, then cooling is carried out to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The bridged ligand form B-114 was obtained as a yellow powder (5.66g, 35% yield).
Weighing the intermediate B-114(5.66g,3.5mmol), adding silver trifluoromethanesulfonate (2.76g,10.5mmol), adding 120ml of dichloromethane into the system, adding 40ml of methanol into the system, refluxing for 48 hours under the protection of nitrogen, cooling to room temperature, and concentrating the filtrate of column chromatography (short column) until solid is separated out. The iridium complex intermediate of formula C-114(6.27g, 91% yield) was obtained as a yellow powder.
Weighing the intermediate C-114(5.90g,6mmol), adding the ligand A-114(5.24g,18mmol), adding 120ml of absolute ethanol into the system, refluxing for 36 hours under the protection of nitrogen, filtering, washing with alcohol, and drying. The final yellow compound of formula I-114 (1.66g, 26% yield) was obtained by silica gel column chromatography using dichloromethane and toluene as solvents and concentrating the filtrate to give a solid which was greater than 99% pure by HPLC.
Mass spectrum calculated 1063.17; the test value was 1063.28.
The calculated value of the elemental analysis (%) > is C: 64.39; h is 3.70; f is 5.36; 18.08 parts of Ir; n is 3.95; o is 4.51, and the test value is C is 64.38; h is 3.71; f is 5.34; 18.07 parts of Ir; n is 3.97; o is 4.52.
Example 9
This example provides an iridium complex of formula I-138, which is prepared by the following reaction scheme:
Figure BDA0003116705420000241
the specific preparation method comprises the following steps:
weighing A-138(14.57g,50mmol), IrC1 of formula A-138 under nitrogen protection system3·3H2O (7.05g,20mmo1) is put into a reaction system, a mixed solution of 300m1 ethylene glycol ethyl ether and 100m1 pure water is added, the mixture is refluxed for 30 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The bridged ligand form B-138(8.24g, 51% yield) was obtained as a yellow powder.
Weighing the intermediate B-138(8.08g,5mmol), adding silver trifluoromethanesulfonate (5.25g,20mmol), adding 160ml of dichloromethane into the system, adding 53ml of methanol, refluxing for 48 hours under the protection of nitrogen, cooling to room temperature, and concentrating the filtrate of column chromatography (short column) until solid is separated out. The iridium complex intermediate of formula C-138(8.76g, 89% yield) was obtained as a yellow powder.
Weighing the intermediate C-138(8.36g,8.5mmol), adding the ligand D-138(9.91g,34mmol), adding 170ml of absolute ethanol into the system, refluxing for 24 hours under the protection of nitrogen, filtering, washing with alcohol, and drying. The final yellow compound of formula I-138 (2.64g, 31% yield) was obtained by silica gel column chromatography using toluene as solvent and concentrating the filtrate to precipitate a solid with an HPLC purity of greater than 99%.
Mass spectrum calculated 1003.14; the test value was 1003.57.
The calculated value of the elemental analysis (%) > is C: 65.85; h is 3.82; f is 3.79; 19.16 parts of Ir; n is 4.19; o is 3.19, and the test value is C is 65.87; h is 3.85; f is 3.79; 19.17 parts of Ir; n is 4.16; o is 3.16.
Example 10
This example provides an iridium complex of formula i-157, which is prepared by the following reaction scheme:
Figure BDA0003116705420000251
the specific preparation method comprises the following steps:
weighing A-157(10.32g,50mmol), IrC1 of formula A under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, a mixed solution of 210m1 ethylene glycol ethyl ether and 70m1 pure water is added, the mixture is refluxed for 30 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. Bridged ligand B-157(6.51g, 51% yield) was obtained as a yellow powder.
Weighing the intermediate B-157(5.74g,4.5mmol), adding silver trifluoromethanesulfonate (3.54g,13.5mmol), adding 120ml of dichloromethane into the system, adding 40ml of methanol, refluxing for 36 hours under the protection of nitrogen, cooling to room temperature, and concentrating the filtrate of column chromatography (short column) until solid is separated out. The iridium complex intermediate of formula C-157(6.89g, 94% yield) was obtained as a yellow powder.
Weighing the intermediate C-157(6.51g,8mmol), adding the ligand D-157(6.19g,20mmol), adding 130ml of absolute ethanol into the system, refluxing for 30 hours under the protection of nitrogen, filtering, washing with alcohol, and drying. The final yellow compound of formula I-157 (1.82g, 25% yield) was obtained by silica gel column chromatography using dichloromethane as solvent and concentrating the filtrate to give a solid which was greater than 99% pure by HPLC.
Mass spectrum calculated 911.18; the test value was 911.43.
The calculated value of the elemental analysis (%) > is C: 61.95; h is 6.41; f is 4.17; 21.10 parts of Ir; n is 4.61; o is 1.76, and the test value is C is 61.95; h is 6.41; f is 4.17; 21.10 parts of Ir; n is 4.61; o is 1.76.
Example 11
This example provides an iridium complex of formula I-176, which is prepared by the following reaction scheme:
Figure BDA0003116705420000261
the specific preparation method comprises the following steps:
formula A-176(17.95g,60mmol), IrC1 was weighed under nitrogen protection3·3H2O (7.05g,20mmo1) is put into a reaction system, a mixed solution of 330m1 ethylene glycol ethyl ether and 110m1 purified water is added, the mixture is refluxed for 24 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence. The bridged ligand B-176 was obtained as a yellow powder (6.43g, 39% yield).
Weighing the intermediate B-176(5.77g,3.5mmol), adding silver trifluoromethanesulfonate (1.98g,7.7mmol), adding 120ml of dichloromethane into the system, adding 40ml of methanol, refluxing for 48 hours under the protection of nitrogen, cooling to room temperature, and concentrating the filtrate of column chromatography (short column) until solid is separated out. The iridium complex intermediate of formula C-176(6.58g, 94% yield) was obtained as a dark yellow powder.
Weighing the intermediate C-176(6.00g,6mmol), adding the ligand D-176(7.65g,18mmol), adding 120ml of absolute ethanol into the system, refluxing for 28 hours under the protection of nitrogen, filtering, washing with alcohol, and drying. The final yellow compound of formula I-176 (1.89g, 26% yield) was obtained by silica gel column chromatography using dichloromethane and toluene as solvents and concentrating the filtrate to give a solid which was greater than 99% pure by HPLC.
Mass spectrum calculated 1212.62; the test value was 1212.90.
The calculated value of the elemental analysis (%) is 38.63; f, 40.73; 15.85 parts of Ir; n is 3.47; o is 1.32, and the test value is C is 38.62; f, 40.71; 15.83 parts of Ir; n is 3.49; o is 1.35.
The synthesis methods of other iridium complexes are the same as those described above, and are not repeated here, and the mass spectrum or molecular formula of other synthesis embodiments is shown in table 1 below:
TABLE 1
Compound (I) Molecular formula Calculated mass spectrum Calculated mass spectrum
Formula I-1 C39H21D4F2IrN2O4 819.88 819.50
Formula I-24 C43H23F12IrN2O4 1051.86 1051.42
Formula I-35 C61H51F4IrN2O4 1144.30 1144.07
Formula I-55 C63H67D2F2IrN2O4 1150.48 1150.76
Formula I-79 C39H6D2F19IrN2O4 1123.70 1123.24
Formula I-107 C50H32F2IrN3O 921.04 921.62
Formula I-121 C75H44F4IrN3O2 1287.41 1287.18
Formula I-130 C57H33F9IrN3O3 1171.11 1171.64
Formula I-146 C58H35D9F2IrN3O2 1054.28 1054.60
Formula I-166 C49H31F13IrN3O 1117.00 1117.49
The embodiment of the invention also provides an organic electroluminescent device prepared by using the iridium complex provided by the embodiment, and specifically, the organic electroluminescent device is an organic electroluminescent device, wherein the organic electroluminescent device comprises a first electrode, a second electrode and at least one organic layer arranged between the first electrode and the second electrode.
The organic layer may include at least one layer selected from a hole injection layer, a hole transport layer, a composite layer of hole injection and hole transport technical layers, an electron blocking layer, an emission layer, a hole blocking layer, an electron transport layer, an electron injection layer, an electron transport layer, and a composite layer of electron injection technical layers, and at least one layer may or may not include the iridium complex.
Specifically, the light-emitting layer includes a host material and a dopant material; wherein, the host material can be 4,4'-N, N' -biphenyl dicarbazole (CBP), but is not limited thereto; the doping material can be the iridium complex.
In practical applications, the method for manufacturing the organic electroluminescent device can refer to device example 1 below.
Device example 1
Embodiment 1 of the device provides a red phosphorescent organic electroluminescent device, and the preparation method comprises the following steps:
coating with a thickness of
Figure BDA0003116705420000281
The ITO glass substrate of (1) was washed in distilled water for 2 times, ultrasonically for 30 minutes, repeatedly washed in distilled water for 2 times, ultrasonically for 10 minutes, and after the washing with distilled water was completed, solvents such as isopropyl alcohol, acetone, and methanol were ultrasonically washed in this order, dried, transferred to a plasma cleaning machine, and the substrate was washed for 5 minutes and sent to an evaporation coater. Under vacuum conditions, the standard pressure was set at 1X 10-6And (4) supporting. Thereafter, the ITO substrate was coated with CuPc
Figure BDA0003116705420000282
Figure BDA0003116705420000283
CBP + Iridium Complex represented by formula I-1 (5%)
Figure BDA0003116705420000284
And
Figure BDA0003116705420000285
Figure BDA0003116705420000286
the sequence of (a) and (b) forming layers of organic material.
Referring to the above-mentioned method, the iridium complexes represented by the formula I-1 were replaced with iridium complexes represented by the formulae I-2, I-11, I-24, I-35, I-44, I-55, I-62, I-79, I-83, and I-96, respectively, to prepare organic electroluminescent devices of the corresponding compounds.
Comparative device example 1
An organic electroluminescent device was fabricated in accordance with the method provided in device example 1, except that the doping material of the light-emitting layer (the iridium complex represented by formula I-1) was replaced with (btp)2Ir(acac)。
Among them, the compounds used in the embodiments of the present invention are copper (II) phthalocyanine (CuPc), NPB, (btp)2Ir(acac),Alq3And the structural formula of CBP is as follows:
Figure BDA0003116705420000287
the organic electroluminescent device prepared as above was subjected to the driving voltage, current efficiency and service life (T95) tests, and the results are shown in table 2.
TABLE 2
Doping material for device Drive voltage (V) Current (mA) Current efficiency (cd/A) T95(h)
(btp)2Ir(acac) 8.1 9 16.9 560
Formula I-1 3.4 9 35.7 1070
Formula I-2 3.2 9 36.4 1050
Formula I-11 3.7 9 39.1 1030
Formula I-24 3.1 9 34.2 1040
Formula I-35 3.3 9 37.2 990
Formula I-44 3.4 9 36.1 1060
Formula I-55 3.8 9 35.1 1040
Formula I-62 3.0 9 35.7 1100
Formula I-79 3.5 9 35.6 1060
Formula I-83 3.2 9 39.5 1070
Formula I-96 3.6 9 34.6 1040
As can be seen from table 1, compared with the existing doped material, under the same current condition, the iridium complex provided by the embodiment of the invention has a lower driving voltage, and the current efficiency and the service life are obviously higher.
Device example 2
Embodiment 2 of the device provides a green phosphorescent organic electroluminescent device, and the preparation method comprises the following steps:
coating with a thickness of
Figure BDA0003116705420000291
The ITO glass substrate of (1) was washed in distilled water for 2 times, ultrasonically for 30 minutes, repeatedly washed in distilled water for 2 times, ultrasonically for 10 minutes, and after the washing with distilled water was completed, solvents such as isopropyl alcohol, acetone, and methanol were ultrasonically washed in this order, dried, transferred to a plasma cleaning machine, and the substrate was washed for 5 minutes and sent to an evaporation coater. Firstly, evaporating N1- (2-naphthyl) -N4, N4-di (4- (2-naphthyl (phenyl) amino) phenyl) -N1-phenyl benzene-1, 4-diamine ('2-TNATA') 60nm on an ITO (anode), then evaporating NPB 60nm, a host substance 4,4'-N, N' -biphenyl dicarbazole ('CBP') and a doping material (an iridium complex shown in a formula I-100) according to a weight ratio of 90:10, mixing and evaporating 30nm, evaporating a hole blocking layer ('BALq') 10 nm), evaporating an electron transport layer ('Alq 3') 40nm, evaporating an electron injection layer LiF 0.2nm, and evaporating cathode Al 150nm to prepare the organic electroluminescent device. The performance luminescence characteristics of the obtained device are tested by adopting a KEITHLEY 2400 type source measuring unit and a CS-2000 spectral radiance luminance meter to evaluate the driving voltage, the service life and the luminescence efficiency.
Referring to the above-mentioned method, the iridium complexes represented by the formulae I-100 are replaced with iridium complexes represented by the formulae I-107, I-114, I-121, I-130, I-138, I-146, I-157, I-166, and I-176, respectively, to prepare organic electroluminescent devices of the corresponding compounds.
Comparative device example 2
An organic electroluminescent device was fabricated by the method provided in device example 2, except that the doping material (iridium complex represented by formula I-100) of the light-emitting layer was replaced with Ir (ppy)3. Wherein, Ir (ppy)3The structural formula of (A) is as follows:
Figure BDA0003116705420000301
the organic electroluminescent device prepared as above was examined for driving voltage, luminous efficiency and service life (T95), and the results are shown in table 3.
TABLE 3
Doping material for device Drive voltage (V) Luminance (cd/cm)2) Efficiency (cd/A) T95(h)
Ir(ppy)3 6.0 5000 23.0 56.1
Formula I-100 3.1 5000 83.4 780
Formula I-107 3.3 5000 86.8 761
Formula I-114 3.4 5000 87.5 792
Formula I-121 3.8 5000 85.6 801
Formula I-130 4.0 5000 88.1 826
Formula I-138 3.5 5000 79.9 751
Formula I-146 3.7 5000 84.2 781
Formula I-157 3.9 5000 90.0 792
Formula I-166 3.8 5000 86.5 738
Formula I-176 3.2 5000 81.9 827
As can be seen from Table 2, the organic electroluminescent device prepared by using the iridium complex provided by the embodiment of the invention as the doping material of the light-emitting layer and the conventional iridium complex Ir (ppy)3Compared with the organic electroluminescent device prepared by the doped material of the luminescent layer, the driving voltage is obviously reduced, and the luminous efficiency and the service life are obviously improved.
Another object of an embodiment of the present invention is to provide a display apparatus, including a functional module and a display module, where the display module includes the above organic electroluminescent device. Specifically, the display device may be a mobile phone, a notebook computer, a tablet computer, and the like, but is not limited thereto.
In light of the foregoing description of the preferred embodiment of the present invention, many modifications and variations will be apparent to those skilled in the art without departing from the spirit and scope of the invention. The technical scope of the present invention is not limited to the content of the specification, and must be determined according to the scope of the claims.

Claims (10)

1. An iridium complex, wherein the iridium complex has a general structural formula of formula I:
Figure FDA0003116705410000011
wherein m is a positive integer of not more than 3, and when m is 3, an a ring is absent; when m is 1 or 2, the ring A is a cyclic structure;
a. b and c are integers, a is more than or equal to 0 and less than or equal to 4, b is more than or equal to 0 and less than or equal to 2, and c is more than or equal to 1 and less than or equal to 4;
x is O or S, Y is N or P;
R1、R2and R3Is at any position of the ring and is independently selected from at least one of hydrogen, deuterium, amino, hydroxyl, halogen, cyano, substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C1-C30 alkoxy, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted 4-30-membered aromatic heterocyclic group, substituted or unsubstituted C10-C30 condensed ring group, substituted or unsubstituted C5-C30 spiro ring; and at least one R3Is fluorine.
2. An iridium complex according to claim 1, wherein R is1,R2,R3At least one group of which forms a ring with the ring structure in which it is located.
3. The iridium complex according to claim 1, wherein the general structural formula of the iridium complex is any one of formula 01 to formula 04:
Figure FDA0003116705410000012
in the formula, R4、R5、R6、R7And R8Each independently selected from hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C30 cycloalkyl, substituted or unsubstituted C6-C30 aryl, substituted or unsubstituted 4-to 30-membered aromatic heterocyclic group, substituted or unsubstituted C10-C30 condensed ring group; r7And R8At any position of the ring;
d. e, f, g and h are integers, d is more than or equal to 0 and less than or equal to 1, e is more than or equal to 0 and less than or equal to 2, f is more than or equal to 0 and less than or equal to 2, g is more than or equal to 0 and less than or equal to 4, and h is more than or equal to 0 and less than or equal to 4.
4. An iridium complex according to claim 3, wherein R is7And/or R8And the ring-shaped structure with the ring-shaped structure.
5. An iridium complex according to claim 3, wherein the iridium complex has a chemical structure of any one of the following formulae:
Figure FDA0003116705410000021
Figure FDA0003116705410000031
Figure FDA0003116705410000041
Figure FDA0003116705410000051
Figure FDA0003116705410000061
Figure FDA0003116705410000071
Figure FDA0003116705410000081
Figure FDA0003116705410000091
Figure FDA0003116705410000101
Figure FDA0003116705410000111
Figure FDA0003116705410000121
Figure FDA0003116705410000131
Figure FDA0003116705410000141
Figure FDA0003116705410000151
Figure FDA0003116705410000161
Figure FDA0003116705410000171
Figure FDA0003116705410000181
Figure FDA0003116705410000191
Figure FDA0003116705410000201
Figure FDA0003116705410000211
Figure FDA0003116705410000221
Figure FDA0003116705410000231
6. a method for producing an iridium complex according to any one of claims 3 to 5, comprising the steps of:
reacting the raw material A with iridium trichloride to obtain an intermediate B;
reacting the intermediate B with the raw material C to obtain the iridium complex; or reacting the intermediate B with silver trifluoromethanesulfonate to obtain an intermediate C, and then reacting the intermediate C with the raw material D to obtain the iridium complex;
wherein the structural formulas of the raw material A and the raw material D are respectively and independently formula A-01 or formula A-02:
Figure FDA0003116705410000241
the structural formula of the raw material C is represented by formula C-01:
Figure FDA0003116705410000242
7. use of an iridium complex as claimed in any one of claims 1 to 5 in the preparation of an organic electroluminescent device.
8. An organic electroluminescent device comprising a first electrode, a second electrode and at least one organic layer disposed between the first electrode and the second electrode, wherein the organic layer comprises the iridium complex as claimed in any one of claims 1 to 5.
9. An organic electroluminescent device according to claim 8, wherein the organic layer comprises a light-emitting layer; the light-emitting layer comprises a host material and a doping material; the doping material partially or entirely comprises the iridium complex.
10. A display device comprising a functional module and a display module, characterized in that the display module comprises the organic electroluminescent device as claimed in claim 8 or 9.
CN202110664383.2A 2021-06-16 2021-06-16 Iridium complex, preparation method thereof, organic electroluminescent device and display device Active CN113402563B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110664383.2A CN113402563B (en) 2021-06-16 2021-06-16 Iridium complex, preparation method thereof, organic electroluminescent device and display device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110664383.2A CN113402563B (en) 2021-06-16 2021-06-16 Iridium complex, preparation method thereof, organic electroluminescent device and display device

Publications (2)

Publication Number Publication Date
CN113402563A true CN113402563A (en) 2021-09-17
CN113402563B CN113402563B (en) 2022-08-12

Family

ID=77684141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110664383.2A Active CN113402563B (en) 2021-06-16 2021-06-16 Iridium complex, preparation method thereof, organic electroluminescent device and display device

Country Status (1)

Country Link
CN (1) CN113402563B (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012006878A (en) * 2010-06-25 2012-01-12 Mitsubishi Chemicals Corp Organometallic complex, luminescent material, organic electroluminescent element material, organometallic complex-containing composition, organic electroluminescent element, organic el display, and organic el illumination
CN104177426A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Blue phosphorescence iridium metal complex, preparation method thereof, and organic electroluminescent device
KR20160072868A (en) * 2014-12-15 2016-06-24 (주)위델소재 Iridium complex compounds and organic electroluminescent device using the same
CN110669077A (en) * 2019-09-27 2020-01-10 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material, preparation method thereof and organic electroluminescent device
CN110698517A (en) * 2019-09-27 2020-01-17 吉林奥来德光电材料股份有限公司 Iridium metal complex, preparation method thereof and organic electroluminescent device
CN111057112A (en) * 2019-12-24 2020-04-24 吉林奥来德光电材料股份有限公司 Phosphorescent compound and preparation method and application thereof
CN111471072A (en) * 2019-11-21 2020-07-31 吉林奥来德光电材料股份有限公司 Organic iridium metal complex and preparation method and application thereof
CN111825724A (en) * 2020-07-28 2020-10-27 奥来德(长春)光电材料科技有限公司 Phosphorescent iridium complex, preparation method thereof and electroluminescent device
CN112010908A (en) * 2020-08-31 2020-12-01 奥来德(上海)光电材料科技有限公司 Iridium complex for red light electroluminescent material, preparation method thereof and photoelectric device

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012006878A (en) * 2010-06-25 2012-01-12 Mitsubishi Chemicals Corp Organometallic complex, luminescent material, organic electroluminescent element material, organometallic complex-containing composition, organic electroluminescent element, organic el display, and organic el illumination
CN104177426A (en) * 2013-05-22 2014-12-03 海洋王照明科技股份有限公司 Blue phosphorescence iridium metal complex, preparation method thereof, and organic electroluminescent device
KR20160072868A (en) * 2014-12-15 2016-06-24 (주)위델소재 Iridium complex compounds and organic electroluminescent device using the same
CN110669077A (en) * 2019-09-27 2020-01-10 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material, preparation method thereof and organic electroluminescent device
CN110698517A (en) * 2019-09-27 2020-01-17 吉林奥来德光电材料股份有限公司 Iridium metal complex, preparation method thereof and organic electroluminescent device
CN111471072A (en) * 2019-11-21 2020-07-31 吉林奥来德光电材料股份有限公司 Organic iridium metal complex and preparation method and application thereof
CN111057112A (en) * 2019-12-24 2020-04-24 吉林奥来德光电材料股份有限公司 Phosphorescent compound and preparation method and application thereof
CN111825724A (en) * 2020-07-28 2020-10-27 奥来德(长春)光电材料科技有限公司 Phosphorescent iridium complex, preparation method thereof and electroluminescent device
CN112010908A (en) * 2020-08-31 2020-12-01 奥来德(上海)光电材料科技有限公司 Iridium complex for red light electroluminescent material, preparation method thereof and photoelectric device

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RAGNI, ROBERTA等: "Iridium(III) Complexes with Sulfonyl and Fluorine Substituents: Synthesis, Stereochemistry and Effect of Functionalisation on their Photophysical Properties", 《CHEMISTRY-A EUROPEAN JOURNAL》 *
徐秋蕾: "新型铱配合物的合成和光致发光、电致发光性能研究", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》 *
马廷春等: "含氟绿光铱配合物的设计、合成及其高效磷光电致发光器件(英文)", 《无机化学学报》 *

Also Published As

Publication number Publication date
CN113402563B (en) 2022-08-12

Similar Documents

Publication Publication Date Title
CN102939295B (en) Bridged benzimidazole-carbene complexes and use thereof in oleds
Hsu et al. Phosphine-oxide-containing bipolar host material for blue electrophosphorescent devices
KR101082258B1 (en) Compound for organic electroluminescent element and organic electroluminescent element
CN100469204C (en) Organic electroluminescent element
KR101338343B1 (en) Organic electroluminescent device material and organic electroluminescent device
EP2080762A1 (en) Compound for organic electroluminescent device and organic electroluminescent device
US20040097725A1 (en) Charge transport compositions and electronic devices made with such compositions
EP1858094A1 (en) Organic compound, charge transport material and organic electroluminescent device
WO2011080972A1 (en) Organic electroluminescent element
EP2388842A1 (en) Organic electroluminescent element
JP2007533774A (en) Transition metal complexes with carbene ligands as light emitters for organic light-emitting diodes
CN112079731A (en) Luminescent auxiliary material and preparation method and application thereof
WO2013174075A1 (en) Iridium complex containing functional group for hole transporting and electroluminescent device thereof
TW201742861A (en) A novel organic electroluminescent compound and an organic electroluminescent device comprising the same
EP3006433A1 (en) Compound, organic light emitting element comprising same, and display device comprising organic light emitting element
CN113004340B (en) Metal complex, organic electroluminescent material and organic electroluminescent element comprising same
CN111892607B (en) N-heterobiphenyl organic compound and application thereof
CN112375071B (en) Organic light-emitting compound and preparation method and application thereof
CN113105440B (en) Organic electroluminescent compound and preparation method and application thereof
CN114075252A (en) Iridium metal compound, light-emitting material, light-emitting layer, and organic electroluminescent device
CN110878054A (en) Imidazole compound and application thereof
CN112125932A (en) Bivalent platinum complex and application thereof
CN110684052A (en) Organic metal iridium complex, preparation method thereof and electroluminescent device
CN110615816B (en) Phosphorescent material, preparation method thereof and organic electroluminescent device containing phosphorescent material
CN111423386A (en) Novel organic material and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant